KAS
IMGN

Kestra Advisory Services’s Immunogen Inc IMGN Stock Holding History

Kestra Advisory Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,787
Closed -$75K – 2369
2022
Q3 		$75K Sell
15,787
-6,956
-31% -$36.7K ﹤0.01% 2007
2022
Q2 		$102K Sell
22,743
-725
-3% -$3.15K ﹤0.01% 1991
2022
Q1 		$112K Buy
23,468
+2,985
+15% +$16.5K ﹤0.01% 1924
2021
Q4 		$152K Sell
20,483
-4,628
-18% -$28.8K ﹤0.01% 1909
2021
Q3 		$142K Sell
25,111
-1,015
-4% -$5.87K ﹤0.01% 2025
2021
Q2 		$172K Sell
26,126
-1,852
-7% -$12.9K ﹤0.01% 1897
2021
Q1 		$227K Buy
+27,978
New +$228K ﹤0.01% 1652

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kestra Advisory Services's IMGN Position: Q4 2022 in Review

Kestra Advisory Services sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 15,787 shares — an estimated $75K sold.

Kestra Advisory Services first reported a position in IMGN in Q1 2021 and held it in 7 quarters. The position peaked at $227K in Q1 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Kestra Advisory Services reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Kestra Advisory Services sold 15,787 Immunogen Inc shares in Q4 2022, an estimated $75K.
  • Kestra Advisory Services first reported a position in Immunogen Inc in Q1 2021 and held it in 7 quarters.
  • Kestra Advisory Services's Immunogen Inc position peaked at $227K in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Kestra Advisory Services's 13F filing for Q4 2022, filed 31 Jan 2023.